Researchers at the Universities of Helsinki and Turku have developed a test to identify those Read More »
Menu
Breakthrough research for improved cancer diagnostics and treatments
iCAN aims to improve outcomes and quality of life of cancer patients.
We do this through cutting-edge research focused on improving understanding in immuno-oncology, tumor microenvironment and development of disease resistance.
Our research projects leverage the iCAN discovery platform to identify new targets and solutions for diagnosing and treating cancer.
Integrating tumor molecular profiling and patients’ health data
The iCAN discovery platform links molecular profiling of tumors with broader health data of cancer patients, acting as a catalyst for breakthrough research and technologies.
The scale of data – 15,000 samples across different cancer types will be profiled by 2026 – enables real impact and broad studies across different cancer types.
The platform will enable an improved understanding of the complex interplay between cancer cells and the host.
Accelerating world-class scientific innovation with the patient in focus
Our approach is to keep the patient in the focus in all activities in developing a research and innovation hub in digital precision cancer medicine.
At the center of the ecosystem is the iCAN discovery platform leveraged in collaborative partnerships among researchers and the life science industry.
09 Mar, 2023
03 Mar, 2023
iCAN had a strong showing in Business Finland’s last Research to Business funding round. Four Read More »
02 Mar, 2023
Posted iniCAN news, potilaan osallisuus, POTKU
In English: iCAN is organizing a series of meetups at Biomedicum, Helsinki. The purpose of Read More »
23 Jan, 2023
Posted iniCAN news, Open positions
Bioinformatician, iCAN Digital Precision Cancer Medicine project for molecular tumor board reporting - apply by Read More »
This week is an iCAN science seminar superweek 👏
🔹Tomorrow we give the floor to Toni Seppälä
@Adductor
NOTE! If you wish to join online, go to
https://ican.fi/ican-science-seminar-series-spring-2023/
🔹Remember also Dr. Moussion's talk on Friday 👉 https://bit.ly/3LJvFUW
@SuomenAkatemia @HUS_fi
iCAN’s strong organoid expertise gained interest at #BioEuropeSpring in Basel this week. Thank you all for the great discussions!
@elisalexndra2 #lifescience #biopharma #biotech
Interested in brain cancer research? We are searching for an enthusiastic post-doc for a project that focuses on understanding the crosstalk be-tween brain microenvironment and brain tumor cells. Please check the details and apply now https://jobs.helsinki.fi/job/POSTDOCTORAL-RESEARCHER/767205002/
#glioblastoma #TME
iCAN is part of the Academy of Finland Flagship Programme and hosted by the University of Helsinki and HUS Helsinki University Hospital
